Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Symposium Mammographicum 2002

Meeting abstract

Review of clinical trials

RE Hendrick

  • Correspondence: RE Hendrick

Breast Cancer Res 2002, 4(Suppl 1):7 doi:10.1186/bcr530

No comments have yet been made on this article.

Post a comment